@ARTICLE{
author={Oh Jiwon,Drulovic Jelena S,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Cheng Ying-Fang,Harp Christopher,Sierzega Malgorzata,Clayton David,Ratchford John,Goodyear Alexandra,Bar-Or Amit},
year={2025},
title={Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={109-109},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit,Oh Jiwon,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Thomas Piia,Sierzega Malgorzata,Clayton David,Cheng Ying Fang,Ratchford John,Goodyear Alexandra,Drulovic Jelena S},
year={2024},
title={Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={1021-1022},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hua Le,Bar-Or Amit,Weber Martin,Habek Mario,Budincevic Hrvoje,Thomas Piia,Napieralski Julie,Ratchford John,Qi Qi,Sierzega M,Drulovic Jelena S},
year={2023},
title={Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={-},
document_type={Meeting Abstract},
}